Bionexus Gene Lab Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 03, 2020 at 09:23 am EST
BioNexus Gene Lab Corporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 23,471 compared to USD 24,173 a year ago. Operating loss was USD 59,543 compared to USD 50,138 a year ago. Net loss was USD 60,035 compared to USD 22,028 a year ago. For the nine months, sales was USD 30,012 compared to USD 73,906 a year ago. Operating loss was USD 172,686 compared to USD 179,560 a year ago. Net loss was USD 174,525 compared to USD 153,892 a year ago.